Prof. Saleh A. Naser

College of MedicineBurnett, School of Biomedical Sciences

University of Central Florida, USA

Professor

Email: Saleh.naser@ucf.edu

Qualifications

1993 Ph.D., New Mexico State University, Medical Microbiology

1988 M.Sc., University of Bridgeport, Biology/Clinical Sciences

1987 B.Sc., Yarmouk University, Medical Technology

Publications (Selected)

1. Greenman, N., Abdelli, L. S., Hassouneh, S. A. D., Ali, S., Johnston, C., Naser, S. A., & Azarian, T. (2024). Impact of propionic acid-rich diets on microbial composition of the murine gut microbiome. Frontiers in Microbiomes, 3, 1451735.
2. Alhendi, A., & Naser, S. A. (2024). In vitro neutralization of IL-6 receptor exacerbates damage to intestinal epithelial cells during Mycobacterium avium paratuberculosis infection. Frontiers in Immunology, 15, 1412800.
3. Lagod, P. P., Abdelli, L. S., & Naser, S. A. (2024). An in vivo model of propionic acid-rich diet-induced gliosis and neuro-inflammation in mice (FVB/N-Tg (GFAPGFP) 14Mes/J): a potential link to autism spectrum disorder. International Journal of Molecular Sciences, 25(15), 8093.
4. Ashiqueali, S. A., Chaudhari, D., Zhu, X., Noureddine, S., Siddiqi, S., Garcia, D. N., ... & Masternak, M. M. (2024). Fisetin modulates the gut microbiota alongside biomarkers of senescence and inflammation in a DSS-induced murine model of colitis. Geroscience, 46(3), 3085-3103.
5. Kuenstner, J. T., Xu, Q., Bull, T. J., Foddai, A. C., Grant, I. R., Naser, S. A., ... & Kruzelock, R. (2024). Cytokine expression in subjects with Mycobacterium avium ssp. paratuberculosis positive blood cultures and a meta-analysis of cytokine expression in Crohn’s disease. Frontiers in cellular and infection microbiology, 14, 1327969.
6. Lagod, P. P., & Naser, S. A. (2023). The role of short-chain fatty acids and altered microbiota composition in autism spectrum disorder: a comprehensive literature review. International Journal of Molecular Sciences, 24(24), 17432.
7. Alhendi, A., & Naser, S. A. (2023). The dual role of interleukin-6 in Crohn’s disease pathophysiology. Frontiers in Immunology, 14, 1295230.
8. Vaccaro, J. A., Qasem, A., & Naser, S. A. (2022). Cathelicidin mediates an anti-inflammatory role of active vitamin D (calcitriol) during M. paratuberculosis infection. Frontiers in Cellular and Infection Microbiology, 12, 875772.
9. Saccon, T. D., Dhahbi, J. M., Schneider, A., Nunez Lopez, Y. O., Qasem, A., Cavalcante, M. B., ... & Masternak, M. M. (2022). Plasma miRNA profile of Crohn’s disease and rheumatoid arthritis patients. Biology, 11(4), 508.
10. Qasem, A., Naser, A. E., & Naser, S. A. (2021). Enteropathogenic infections modulate intestinal serotonin transporter (SERT) function by activating Toll-like receptor 2 (TLR-2) in Crohn’s disease. Scientific Reports, 11(1), 22624.
11. Shaw, A. M., Qasem, A., & Naser, S. A. (2021). Modulation of PTPN2/22 function by spermidine in CRISPR-Cas9-edited T-cells associated with Crohn’s disease and rheumatoid arthritis. International journal of molecular sciences, 22(16), 8883.
12. Qasem, A., Shaw, A. M., Elkamel, E., & Naser, S. A. (2021). Coronavirus disease 2019 (COVID-19) diagnostic tools: a focus on detection technologies and limitations. Current issues in molecular biology, 43(2), 728-748.
13. Keewan, E. A., Beg, S., & Naser, S. A. (2021). Anti-TNF-α agents modulate SARS-CoV-2 receptors and increase the risk of infection through Notch-1 signaling. Frontiers in Immunology, 12, 641295.
14. AlQasrawi, D., Naser, E., & Naser, S. A. (2021). Nicotine increases macrophage survival through α7nAChR/NF-κB pathway in Mycobacterium avium paratuberculosis infection. Microorganisms, 9(5), 1086.
15. Kuenstner, J. T., Potula, R., Bull, T. J., Grant, I. R., Foddai, A., Naser, S. A., ... & Shafran, I. (2020). Presence of infection by Mycobacterium avium subsp. paratuberculosis in the blood of patients with Crohn’s disease and control subjects shown by multiple laboratory culture and antibody methods. Microorganisms, 8(12), 2054.
16. Keewan, E. A., & Naser, S. A. (2020). MiR-146a rs2910164 G> C polymorphism modulates Notch-1/IL-6 signaling during infection: a possible risk factor for Crohn’s disease. Gut Pathogens, 12, 1-10.
17. Qasem, A., Elkamel, E., & Naser, S. A. (2020). Anti-MAP triple therapy supports immunomodulatory therapeutic response in Crohn’s disease through downregulation of NF-κB activation in the absence of MAP detection. Biomedicines, 8(11), 513.

Profile Details

WoS ResearcherID: FZR-1097-2022

https://med.ucf.edu/biomed/person/dr-saleh-a-naser/

https://scholar.google.com.hk/citations?hl=zh-CN&user=nQ8rkisAAAAJ

https://www.researchgate.net/lab/Saleh-A-Naser-Lab